EMA validates Bristol Myers Squibb’s two Opdivo-based applications to treat cell carcinoma
The applications are based on positive results from the phase-III CheckMate-648 trial, in which both Opdivo-based combinations…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.